Showing results (201-210 of 211) with videos related to
Sort By:
Pageof 22
Journal of Nematology|June 28, 2021
<i>Meloidogyne aegracyperi</i> n. sp. (Nematoda: Meloidogynidae), a root-knot nematode parasitizing yellow and purple nutsedge in New MexicoJ D Eisenback, L A Holland, J Schroeder, et al.Clinical Toxicology (Philadelphia, Pa.)|March 12, 2013
Assessing the toxicity and associated costs among pediatric patients admitted with unintentional poisonings of attention-deficit/hyperactivity disorder drugs in the United StatesM Levine, B Froberg, A M Ruha, et al.Integrative Biology : Quantitative Biosciences From Nano to Macro|May 5, 2011
The challenges of integrating molecular imaging into the optimization of cancer therapyG S Patel, T Kiuchi, K Lawler, et al.European Journal of Clinical Pharmacology|January 1, 1992
Differential cardiovascular effects of propranolol, atenolol, and pindolol measured by impedance cardiographyS H Thomas, R C Cooper, M Ekwuru, et al.Qatar Medical Journal|May 12, 2020
Characterizing Agreement in the Level of Interarm Blood Pressure Readings of Adults in the Emergency Department (CALIBRATE Study)Z A Bhutta, I Qureshi, M Shujauddin, et al.Human & Experimental Toxicology|November 5, 1997
Paracetamol poisoning in the north east of England: presentation, early management and outcomeS H Thomas, J E Horner, K Chew, et al.Human & Experimental Toxicology|June 1, 1996
Presentation of poisoned patients to accident and emergency departments in the north of EnglandS H Thomas, L Bevan, S Bhattacharyya, et al.Human & Experimental Toxicology|November 1, 1996
Factors affecting hospital admission and length of stay of poisoned patients in the north east of EnglandS H Thomas, S Lewis, L Bevan, et al.Bone Marrow Transplantation|September 25, 2012
A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplantS K Khaled, J Palmer, T Stiller, et al.Bone Marrow Transplantation|December 15, 2010
Phase-2 trial of an intensified conditioning regimen for allogeneic hematopoietic cell transplant for poor-risk leukemiaA S Stein, M R O'Donnell, T W Synold, et al.Pageof 22